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Solid state 2H NMRMarine long chain n-3 polyunsaturated fatty acids (PUFA), eicosapentaenoic (EPA) and docosahexaenoic acid
(DHA), are bioactive molecules with clinical applications for the treatment of several diseases. In order to effec-
tively translate these molecules into clinical trials, it is essential to establish the underlying mechanisms for n-3
PUFA. This review focuses on efforts to understand how EPA and DHA, upon incorporation into plasma mem-
brane phospholipids, remodel the molecular organization of cholesterol-enriched lipid microdomains. We ﬁrst
give an overview of results from studies on cells. Paradoxical data generated from mouse studies indicate that
EPA and DHA incorporate into lipid microdomains, yet in spite of their high disorder increase molecular order
within the domain. We then spotlight the utility of solid state 2H NMR spectroscopy of model bilayers as a tool
for elucidating underlying mechanisms bywhich n-3 PUFA-containing phospholipids can regulatemolecular or-
ganization of lipidmicrodomains. Evidence is presented demonstrating that n-3 PUFA exert differential structural
effects when incorporated into phosphatidylethanolamines (PE) compared to phosphatidylcholines (PC), which
explains some of the conﬂicting results observed in vivo. Recent studies that reveal differences between the in-
teractions of EPA and DHA with lipid microdomains, potentially reﬂecting a differential in bioactivity, are ﬁnally
described. Overall, we highlight the notion that NMR experiments on model membranes suggest a complex
model by which n-3 PUFA reorganize lipid microdomains in vivo. This article is part of a Special Issue entitled:
NMR Spectroscopy for Atomistic Views of Biomembranes and Cell Surfaces. Guest Editors: Lynette Cegelski and
David P. Weliky.
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The consumption of eicosapentaenoic (EPA, 20:5) and docosa-
hexaenoic (DHA, 22:6) acids (Fig. 1), long chain omega-3 polyunsatu-
rated fatty acids (n-3 PUFA) found in marine oils, is low in the
Western diet due to increased consumption of n-6 PUFAs [1]. Numerous
clinical studies suggest potential beneﬁts of n-3 PUFA consumption on
various disease endpoints [2]. Therefore, there is tremendous interest
in increasing the dietary intake for the general public and for select clin-
ical populations through the use of n-3 PUFA enriched over-the-counter
and prescription supplements. A major impediment to clinical transla-
tion is an incomplete understanding of the mechanism of action. The
mechanisms for EPA andDHAare highly pleiotropic and include serving
as substrates for the generation of specialized pro-resolving lipid medi-
ators, changes in gene expression, disruption of cytoskeletal organiza-
tion, modiﬁcation of gene expression, serving as a ligand to GPR120
and alteration of plasma membrane microstructure [3].
This review focuses on the incorporation of n-3 PUFA into phospho-
lipids (Fig. 2a) and their role in remodeling the architecture of plasma
membrane signaling lipid microdomains. Lipid microdomains, com-
monly referred to as rafts, are highly ordered regions enriched in
sphingolipids and cholesterol (Fig. 2b) that serve to increase the prox-
imity of signaling proteins and thereby enhance cellular function [4].
We begin with a survey of results obtained with biological membranes
followed by the insight gleaned from solid state 2H NMR studies of
model membranes.2. Murine and cell culture studies
2.1. n-3 PUFA incorporate directly into crude lipid domains and
displace cholesterol
Over the past decade, in vitro studieswith a variety of cell types have
revealed that EPA or DHA incorporate directly into membrane fractions
that are detergent resistant (DRM, detergent resistant membranes) and
crudely correspond to rafts [5–9]. The incorporation of n-3 PUFA into
DRM is generally into the most abundant phospholipids, i.e. phosphati-
dylcholine (PC) and phosphatidylethanolamine (PE) [10,11]. Highly
similar results were reported with in vivo studies in which the diets of
rodents were supplemented with n-3 PUFA ethyl esters or marine oils
[12,13]. The increase of n-3 PUFA levels in DRM is usually accompanied
by a signiﬁcant reduction in the n-6 PUFA arachidonic acid (AA), a high-
ly disordered fatty acid [3,14]. As a consequence of the change in DRMEPA
DHA
Fig. 1.Molecular structures of EPA (20:5Δ5,8,11,14,17) and DHA (22:6Δ4,7,10,13,16,19).fatty acid composition with n-3 PUFA, a signiﬁcant change in the lateral
organization of plasma membrane signaling proteins is routinely ob-
served with cells from culture and from animals [5,7,13,15–18].
Several laboratories have addressed the impact of the uptake of EPA
and DHA into DRM on the lateral distribution of cholesterol. The recog-
nition that cholesterol plays a key role in the formation of ordered lipid
microdomains was the motivation for the studies [4]. An increasing
number of these studies have shown that n-3 PUFA lower the levels of
cholesterol in DRM, which is hypothesized to be the mechanism by
which protein lateral organization and subsequent signaling ismodiﬁed
with n-3 PUFA [19,20]. The consequence of lowering the amount of cho-
lesterol in DRM with n-3 PUFA on the detergent soluble fraction of a
membrane (DSM, detergent soluble membranes) remains unclear.
There are observations that are consistent with the notion that n-3
PUFA have a poor afﬁnity for cholesterol as revealed in studies of
model membranes that will be described below [21–24]. The treatment
of a neuroblast-like cell line, for example, was shown to displace
cholesterol from DRM to DSM [19]. Similarly, it was recently reported
that a diol of DHA relocated cholesterol from DRM to DSM in a glia
cell line [25].
In some cell types such as breast cancer cells, cholesterol levels in
DRM were lowered upon incorporation of n-3 PUFA into the DRM
with no change in DSM cholesterol levels [6]. One explanation for the
speciﬁc reduction in DRM cholesterol is that cholesterol associated
with rafts is internalized into the cell in response to n-3 PUFA. Lee
et al. showed that treatment of cells with DHA decreased raft-
associated cholesterol levels and expression of GM1 (a marker for
rafts) on the plasmamembrane surface [26]. The reduction in cholester-
ol was driven by internalization of the lipids into lysosomes. Thus, n-3
PUFA appear in some cell types to promote internalization of lipid mi-
crodomains. An additional mechanism by which n-3 PUFA remodel
DRMsmay be that EPA and DHA incorporate directly into sphingolipids
or esterify cholesterol. Indeed, in vivo lipidomics with B cells revealed
that n-3 PUFAs incorporate directly into sphingolipids and can esterify
cholesterol [11,27].
2.2. n-3 PUFA increase the molecular order of lipid microdomains
Although biochemical studies have established that n-3 PUFA incor-
porate into DRM and displace cholesterol, there are signiﬁcant limita-
tions to this approach. The most obvious is the use of detergent, which
introduces artifacts and does not accurately model the nanoscale archi-
tecture of lipid microdomains [28]. Therefore, a few studies have
attempted to understand how n-3 PUFA impact the molecular order of
lipid microdomains using quantitative imaging with polarity sensitive
probes. These studies revealed, contrary to expectation, that n-3 PUFA
increase the molecular order of lipid microdomains.
Experimentswithmousemodels showed that n-3 PUFA enhance the
formation of ordered lipidmicrodomains on the T cell side of the immu-
nological synapse, thehighly organized cholesterol-dependent interface
between CD4+ T cells and antigen presenting cells. Themolecular order
of the immunological synapse was increased by n-3 PUFA, as measured
by two-photon ﬂuorescence of the polarity sensitive probe Laurdan,
accompanied by signiﬁcant remodeling of the actin cytoskeleton
[16,29,30]. These studies also revealed that the changes in themolecular
order of the synapse with n-3 PUFA have an impact on the recruitment
of select proteins into the synapse,which lead to a suppression in down-
stream T cell activation and proliferation [16,29].
ab
Fig. 2. Representative molecular structures of a. PUFA-containing phospholipids PEPC, PDPC and PDPE; and b. raft-forming lipids SM and cholesterol.
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distribution and order of lipid microdomains on the surface of B lym-
phocytes and EL4 T lymphomas [11]. n-3 PUFA administered tomice de-
creased the clustering of lipid microdomains that were induced to form
in response to cholera toxin subunit b clustering of GM1 molecules.
Nearly identical results were observed upon treatment of EL4 cells
with DHA, but not EPA. This observation was interpreted in terms of
an increase in the size of the lipid microdomains, based on confocal im-
aging of GM1 clusters on a micron scale. Whether n-3 PUFA actually in-
creased the size of the clusters is debatable though, since nanoscale
measurements were not conducted in parallel with appropriate high-
resolution imaging.
Subsequent studies showed that B cells isolated frommice consum-
ing n-3 PUFA displayed a reduction in generalized polarization of di-4-
ANEPPDHQ, demonstrating a decrease in microviscosity with n-3
PUFA [11]. Relative to the absence of crosslinking, however, n-3 PUFA
increased the polarization of di-4-ANEPPDHQ upon crosslinking GM1
molecules. Again, the change in lipid microdomain organization with
n-3 PUFA disrupted the ability of a protein to accumulate on the B cell
side of the immunological synapse, as demonstratedwith FRET and con-
focal imaging, which led to suppressed cellular function [15]. The effects
were recapitulated, furthermore, in the absence of n-3 PUFA with cho-
lesterol depletion suggesting a cholesterol-mediated mechanism. The
ordering effect upon lipid microdomain formation was found to be
more robust with DHA than EPA in cell culture studies [11].2.3. The paradox of biochemical and imaging studies on n-3 PUFA
A clear paradox emerges from the biochemical and imaging studies.
How n-3 PUFA acyl chains, which are highly disordered structures, in-
corporate directly into lipid microdomains yet increase the molecular
order is a mystery. Thus, the mechanism by which n-3 PUFA modiﬁes
the molecular order and formation of cholesterol-enriched microdo-
mains remains elusive. One approach to solving this problem is to use
protein-free model bilayers of controlled composition to elucidate the
basic molecular interactions between n-3 PUFA-containing phospho-
lipids, cholesterol and sphingolipids. We now direct the reader's atten-
tion to the application of solid state 2H NMR spectroscopy in this
endeavor. The salient features of the method and what has been learnt
about themolecular organization of n-3 PUFA-containing phospholipids
are ﬁrst brieﬂy covered, and then advances made in the past several
years on how speciﬁc species of n-3 PUFA-containing phospholipid dif-
ferentially interact with lipid microdomains are highlighted.3. Solid state 2H NMR of model membranes
Solid state 2H NMR of deuterated analogs of lipidmolecules offers an
essentially non-invasive method for studying molecular organization
within membranes. Isotopic substitution of 2H for 1H constitutes a min-
imal perturbation, while interpretation of the spectra is relatively
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interaction that dominates the spectral shape. There are excellent re-
views, for instance by Davis [31], that give a comprehensive treatment
of spectral analysis. The description here is meant merely to aid an ap-
preciation of the data that will be discussed.
The spectrum for 1-[2H31]palmitoyl-2-oleoylphosphatidylcholine
([2H31]16:0-18:1PC, POPC-d31) at 30 °C exempliﬁes the form of spectra
obtainedwith analogs of phospholipids that are perdeuterated through-
out a saturated sn-1 chain in the physiologically relevant lamellar liquid
crystalline state (Fig. 3a, upper) [32]. Because the sample consists of bi-
layers randomly oriented in an aqueous medium relative to the direc-
tion of the magnetic ﬁeld, the spectrum is a powder pattern that is
comprised of a superposition of signals from bilayers at all orientations.
At each orientation, moreover, the signal is a superposition of doublets
from each position of deuteration along the perdeuterated sn-1 chain.
The resultant spectrum has well deﬁned edges at ~±13 kHz due to a
plateau region of virtually constant order for methylene groups in the
upper portion of the chain, while the individual peaks within the spec-
trum arise from less ordered methylene groups in the lower portion of
the chain and the highly disordered terminal methyl group produces
the central pair of peaks.
3.1. Moment analysis
Lineshape analysis is the way details of molecular organization are
extracted from the spectrum [31]. The ﬁrst moment
M1 ¼
Z∞
−∞
ωj j f ωð Þdω
Z∞
−∞
f ωð Þdω
ð1ÞFig. 3. 2H NMR of POPC-d31 bilayers at 30 °C. a. Powder pattern (upper) and depaked
(lower) spectra, and b. an order parameter proﬁle derived from the depaked spectrum.
The numbers next to peaks in the depaked spectrum designate the carbon positions to
which they are assigned, while the asterisk is an artifact associated with the depaking
algorithm that is ignored [37].is related to the average order parameter SCD for the perdeuterated sn-1
chain by
M1 ¼
πﬃﬃﬃ
3
p e
2qQ
h
 !
SCD
 : ð2Þ
In these equations ω is the frequency relative to the central Larmor
frequency ω0, f(ω) is the lineshape and
e2qQ
h
 
¼ 168 kHz is the static
quadrupolar coupling constant. The order parameter is deﬁned accord-
ing to
SCD ¼
1
2
3 cos2β−1
D E
; ð3Þ
where β is the time-dependent angle that the C\2H bond in a methy-
lene or methyl group makes with the bilayer normal and the angular
brackets denote a time average [33]. It speciﬁes the degree of anisotropy
for the motion of chain segments relative to the bilayer normal about
which lipid chains rapidly reorient with axial symmetry. Values in the
range0≤ SCDj j≤ 12 are typically taken, the lower limit representing effec-
tively isotropic motion while the upper limit signiﬁes fast axial rotation
in an all-trans conﬁguration. The interpretation can be complicated by
geometric factors due to conformational constraints imposed, for in-
stance, by the glycerol backbone on the beginning of the sn-2 chain in
PC bilayers [34] and by the rigidity of a double bond on the unsaturated
segment in a lipid chain [35].
3.2. Depaking
Amore sophisticated level of analysis is achieved with the depaking
algorithm that converts the spectrum for a multilamellar dispersion to
one that corresponds to a sample of single alignment [36,37]. As demon-
strated for POPC-d31, the depaked spectrum consists of an outermost
composite doublet produced by the plateau region of similarly ordered
methylene groups in the upper portion of the chain and 6well-resolved
doublets with progressively less splitting due to the disordered methy-
lene and terminal methyl groups in the lower portion of the chain
(Fig. 3a, lower). The quadrupolar splitting Δυ(θ) for each doublet
equates to an order parameter SCD via
Δυ θð Þ ¼ 3
2
e2qQ
h
 !
SCDj jP2 cos θð Þ ð4Þ
where θ= 0° is the angle that the bilayer normal makes with the mag-
netic ﬁeld and P2(cos θ) is the second order Legendre polynomial.
Exploiting the enhanced resolution of the depakeddata, a smoothedpro-
ﬁle of the gradient of order parameter along a chain is then generated on
the basis of integrated intensity assuming monotonic variation from the
top to bottom of the chain [38]. The general shape of the proﬁle plotted
for POPC-d31, with its plateau of slowly varying order (SCD ~ 0.20) in the
upper part of the chain (positions C2-9) followed by an increasing drop-
off in order toward the terminalmethyl end (SCD≈ 0.02) at the center of
the bilayer (positions C10-16) (Fig. 3b), is a signature of phospholipid
membranes [33]. It should be borne in mind that subtleties in the varia-
tion of order within the plateau region are not discerned by this ap-
proach. The overall shape of the gradient of molecular ordering within
the bilayer is nonetheless captured.
4. Molecular organization of PUFA-containing phospholipids
4.1. PUFA-containing phospholipids are highly disordered
When EPA and DHA are taken up into phospholipids in the plasma
membrane, the incorporation occurs at the sn-2 positionwhile a saturat-
ed fatty acid occupies the sn-1 position (Fig. 2a) [39]. The n-3 PUFA-
containing phospholipids produced are substantially more disordered
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acids such as oleic acid (OA) that with just a single double bond is most
abundant. This view was substantiated by 2H NMR work on 1-[2H31]
palmitoyl-2-docosahexaenoylphosphatidylcholine ([2H31]16:0-22:6PC,
PDPC-d31), a DHA-containing analog of PC with perdeuterated palmitic
acid for the sn-1 chain, from the Brown group [40] and on 1-[2H35]
stearoyl-2-eicosapentaenoylphosphatidylcholine ([2H35]18:0-20:5PC,
SEPC-d35) and 1-[2H35]stearoyl-2-docosahexaenoylphosphatidylcholine
([2H35]18:0–22:6PC, SDPC-d35), EPA and DHA-containing analogs of PC
with perdeuterated stearic acid for the sn-1 chain, from the Gawrisch
group [41]. The behavior is illustrated by average order parameters mea-
sured for SEPC-d35 SCD ¼ 0:129
 
and SDPC-d35 SCD ¼ 0:133
 
at 35 °C
in our laboratory. They are reduced, EPA somewhat more than DHA, by
~10% with respect to monounsaturated 1-[2H35]stearoyl-2-oleoyl-
phosphatidylcholine ([2H35]18:0–18:1PC, SOPC-d35) SCD ¼ 0:145
 
with
OA for the sn-2 chain.While the saturated sn-1 chain retains the same gen-
eral shape of proﬁle for the order parameter following substitution of EPA
andDHA for OA at the sn-2 position, the change in order is inhomogeneous
along the chain (Fig. 4). There is just a slight shortening (1–2 segments) and
lowering (ΔSCD b 0.01) of the plateau region of virtually constant order in
the top half. In the bottomhalfwhere order fallsmore rapidly, the lowering
is greater and maximized near the C14 position (ΔSCD ~ 0.03). An increase
in area for the sn-1 chain that becomes larger toward the terminal methyl
end, which suggests a wedge shape that is fatter at the center of the
PUFA-containing bilayer, is implied [41].
The tremendously high disorder of n-3 PUFA at the sn-2 position is
responsible for the reduction in order seen for the sn-1 chain relative
to monounsaturated equivalents. In SDPC, which has been comprehen-
sively examined, order parameters measured throughout most of the
DHA chain are very small (SCD ~ 0.01) [42]. They are comparable to the
value for the terminal methyl in the saturated sn-1 chain. Only at the
C2 and C3 positionswhere the glycerol backbone restricts the initial con-
formation of the sn-2 chain are values for the order parameter apprecia-
bly higher (SCD ~ 0.1), albeit still much less than in the sn-1 chain at the
corresponding positions. The presence of a repeating =CH–CH2–CH=
unit that accompanies the multiple double bonds in PUFA is the origin
of the high disorder. The shallow energy barrier to rotation about C\C
bonds within this recurring motif produces an extremely ﬂexible struc-
ture [43]. Based upon an analysis of 13C NMR relaxation times measured
in magic angle spinning (MAS) experiments on SDPC, DHA chains were
calculated to isomerizewith correlation times that decrease fromaround
80 ps for carbons near the carbonyl group to a few ps approaching the
terminal methyl group [44]. The isomerization is so rapid that, except
for the very top, the chain explores its entire conformational space in
50 ns. Included among the torsional states adopted, as visualized inFig. 4.Order parameter proﬁles derived from depaked spectra for SEPC-d35, SDPC-d35 and
SOPC-d35 at 35 °C.MD simulations, are bent conﬁgurations that bring the lower portion of
the chain up to the membrane surface [45].4.2. PUFA-containing phospholipids are cholesterol-phobic
Cholesterol is found in high abundance inmammalian plasmamem-
branes, sometimes reaching asmuch as 45mol% of the total lipid [46]. It
globally modulates molecular organization and its unequal afﬁnity for
different lipids promotes the formation of domains [47]. The cholesterol
molecule consists of a tetracyclic ring structurewith a hydroxyl group at
one end and a short hydrocarbon tail at the other (Fig. 2b). In mem-
branes the hydroxyl group usually sits just below the surface while
the long molecular axis extends toward the interior, lining up approxi-
mately parallel to the lipid chains [48]. PUFA chainswith theirmultitude
of rapidly changing conformations push away the rigid steroid moiety
so that PUFA-containing phospholipids have poor afﬁnity for cholester-
ol [49]. An afﬁnity for PDPC that is about 50% of POPCwas determined in
assays of the partitioning between large unilamellar vesicles (LUV) and
cyclodextrin [50,51].
A deﬁnitive demonstration of the aversion PUFA have for cholesterol
comes from the 2H NMR spectrum observed for [3α-2H1]cholesterol, an
analog of cholesterol selectively labeled with deuterium at the 3α posi-
tion, mixed with 1,2-diarachidonylphosphatidylcholine (20:4–20:4PC,
DAPC) membranes in 1:1 mol amount [24]. The spectrum is comprised
of a narrow component from cholesterol within the membrane super-
posed upon a broad component due to solid cholesterol that is excluded
from the membrane. By comparing the integrated intensity of the two
spectral components, a solubility of 17 mol% was estimated. This value
in DAPC with arachidonic acid that has 4 double bonds at both sn-1
and -2 positions contrasts with less unsaturated membranes, including
mixed chain PC with a saturated sn-1 chain and a polyunsaturated sn-2
chain, that can incorporate≥50mol% cholesterol. It is clear that most of
the sterol is driven out of themembranewhen contactwith PUFA chains
is unavoidable in the dipolyunsaturated system, neutron scattering data
revealing that sterol remaining within the DAPC bilayer is forced to the
center [52,53].Measurements of solubility also establish that the afﬁnity
of cholesterol for phosphatidylethanolamine (PE) ismore sensitive than
PC to the presence of DHA at the sn-2 position (Fig. 5) [21].Whereas the
amount of cholesterol that can be introduced into SDPC (55 ± 3 mol%)
[23] is notmuch less than POPC (65±3 mol%) [54], there is an apprecia-
ble cut in the concentration that can be accommodated in 1-palmityol-2-
docosahexaenoylphosphatidylethanolamine (16:0–22:6PE, PDPE) (31 ±
3 mol%) compared to 1-palmitoyl-2-oleoylphosphatidylethanolamine
(16:0–18:1PE, POPE) (51 ± 3 mol%) [21]. Tighter lipid packing that
accompanies the smaller headgroup of PE offers a possible explanation.
Sterol and PUFA would then be brought nearer together which is
unfavorable.0
20
40
60
80
PC PE
Ch
ol
es
te
ro
l s
ou
bi
lity
(m
ol%
)
OA
DHA
Fig. 5. Solubility of cholesterol in OA- and DHA-containing PC and PE. Values were taken
from Huang et al. (POPC) [54], Brzustowicz et al. (SDPC) [24] and Shaikh et al. (POPE
and PDPE) [21].
Fig. 6. 2H NMR spectra at 40 °C. a. PDPE-d31/SM (1:1 mol) and PDPE-d31/SM/cholesterol
(1:1:1 mol) (left), and POPE-d31/SM (1:1 mol) and POPE-d31/SM/cholesterol
(1:1:1 mol) (right); and b. PDPC-d31/SM (1:1 mol) and PDPC-d31/SM/cholesterol
(1:1:1 mol) (left), and POPC-d31/SM (1:1 mol) and POPC-d31/SM/
cholesterol (1:1:1 mol) (right).
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in mixed membranes with raft-forming sphingomyelin
and cholesterol
The conformational dynamics of PUFA-containing phospholipids are
the complete opposite of sphingolipids found in rafts that are predomi-
nantly saturated [55]. Quadrupolar splittings recently measured for
deuterated analogs of sphingomyelin (SM) (Fig. 2b), a common
sphingolipid, selectively labeled in the sphingosine and amide-linked
chains exhibit a proﬁle of order resembling in form that along the sn-1
and -2 chains, respectively, in disaturated PC [56,57]. Ordering is partic-
ularly elevated as judged, for instance, by a comparison of an average
order parameter reported for PSM-d31, an analog with perdeuterated
palmitic acid for the amide chain, SCD ¼ 0:221
 
that is more than
50% higher than POPC-d31 SCD ¼ 0:144
 
at the same temperature
(40 °C) [58]. A preponderance of trans conformerswithin the SM chains
produces a largely linear conﬁguration that is compatible with close
proximity to the smooth façade presented by the 4 rigid cycloalkane
rings of cholesterol. There is consequently high afﬁnity for the sterol
[59] that is generally believed to play a fundamental role in driving
the formation, aswell asmaintaining the stability, of lipid rafts enriched
in sphingolipids and cholesterol [4].
On the one hand, the extreme disorder of n-3 PUFA-containing
phospholipids suggests that their incorporation into rafts has enormous
potential to modify the organized molecular architecture therein. The
aversion of n-3 PUFA-containing phospholipids for cholesterol, on the
other hand, suggests that they may tend to segregate into non-raft re-
gions that are relatively poor in the sterol. Experimental evidence dem-
onstrating that, dependent upon the species of PUFA-containing
phospholipid, these two scenarios can occur in model membranes is
now presented.
5.1. DHA-containing PE prefers a non-raft environment
We explored the molecular organization of PDPE in mixed mem-
branes with SM and cholesterol in a series of publications [22,60–62].
Minimal incorporation into raft-like domains enriched in SM and cho-
lesterol for PDPE, which instead preferentially segregates into non-raft
domains that are depleted in cholesterol, was inferred from the results
of a variety of techniques. 2H NMR spectra recorded for PDPE-d31 and
POPE-d31 (as a control), analogs with perdeuterated palmitic acid ester-
iﬁed at the sn-1 position, in mixtures with SM (1:1 mol) and with SM
and cholesterol (1:1:1 mol) were important in establishing this view
[22]. Representative examples acquired at 40 °C are shown in Fig. 6a.
They possess the shape that is symptomatic of phospholipids in the
lamellar liquid crystalline phase. Although only a single spectral compo-
nent is discernible, the formation of PE-rich (less ordered) and SM-rich
(more ordered) domainswas concluded because the spectra differ from
those for each PE individually and for PSM-d31 by itself or mixed with
each PE [61]. The domains must be small enough to allow the deuterat-
ed analogs to exchange via lateral diffusion between them at a rate
faster than the difference in the quadrupolar splitting in the two envi-
ronments, and so lead to a spectrum that is a time average. An upper
limit of b20 nm, corresponding to b1800 lipidmolecules,was estimated
taking spectra obtained for PDPE-d31 and PSM-d31 to be representative
of PE-rich and SM-rich domains in PDPE/SM/cholesterol.
Close inspection of the spectra shown in Fig. 6a also reveals that
broadening due to the restriction to chainmotion caused by introducing
cholesterol, clearly evident in the sharp shoulders associated with the
plateau region of slowly varying order in the upper portion of the sn-1
chain, is appreciably less marked for PDPE-d31 (spectra on left) than
POPE-d31 (spectra on right). As graphically depicted in Fig. 7a, the in-
crease in average order parameter caused by the sterol that was calcu-
lated from the ﬁrst moment for PDPE-d31 ΔSCD ¼ 0:039
 
is less thanhalf for POPE-d31 ΔSCD ¼ 0:100
 
[22]. The smaller effect is in accord
with a greater propensity to partition into domains that are sterol-
poor for DHA-containing PE relative to OA-containing PE. How much
PDPE-d31 and POPE-d31 distribute between domains could not be
determined from the spectra. An indication comes from detergent ex-
traction experiments conducted on PDPE/SM/cholesterol and POPE/
SM/cholesterol membranes (1:1:1 mol). More than 3× as much PDPE
(~70%) as POPE (~22%) was isolated in DSM (“non-raft”) fractions at
4 °C, while as expected almost all SM and cholesterol (N90%) was
found in DRM (“raft-like”) fractions in both systems [22].
5.2. DHA-containing PC invades raft-like domains
In subsequent 2H NMR studies on PDPC-d31 in mixed membranes
with SM (1:1mol) andwith SM and cholesterol (1:1:1 mol), somewhat
surprisingly in view of our results on PDPE-d31, we discovered that a
substantial amount of DHA-containing PC can inﬁltrate raft-like
domains [11,63]. From an examination of the spectra plotted in
Fig. 6b, it can be seen that adding cholesterol broadens the spectrum
for PDPC-d31 (spectra on left) to a much greater extent than PDPE-d31
(Fig. 6a, spectra on left) at 40 °C. The increase in average order parame-
ter due to the sterol calculated for PDPC-d31 ΔSCD ¼ 0:075
 
from the
spectra, albeit still less than POPC-d31 ΔSCD ¼ 0:092
 
that constitutes
our control, is nearly twice that for PDPE-d31 (Fig. 7b). A much greater
tendency to accumulate with cholesterol and SM in domainsmimicking
the lipid composition of rafts is implied for PDPC over PDPE.
Fig. 8. 2HNMRspectra at 30 °C for PDPC-d31/SM/cholesterol (1:1:1mol) (left column) and
PEPC-d31/SM/cholesterol (1:1:1 mol) (right column). Powder pattern (lower) and
depaked (upper) spectra, together with an expansion of the central region in each case,
are shown. The arrows designate pairs of signals assigned to the terminal methyl group
on PDPC-d31 and PEPC-d31 in more disordered PC-rich/cholesterol-poor (inner) and
more ordered SM-rich/cholesterol-rich (outer) domains. A Gaussian ﬁt (dashed lines)
was applied to the peaks in the depaked spectra.
Fig. 7.Average order parameterSCD derived from 2HNMR spectra at 40 °C. a. PDPE-d31/SM
(1:1 mol) and PDPE-d31/SM/cholesterol (1:1:1 mol), and POPE-d31/SM (1:1 mol) and
POPE-d31/SM/cholesterol (1:1:1 mol); and b. PDPC-d31/SM (1:1 mol) and PDPC-d31/SM/
cholesterol (1:1:1 mol), and POPC-d31/SM (1:1 mol) and POPC-d31/SM/cholesterol
(1:1:1 mol).
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spectrum for PDPC-d31/SM is apparent following the addition of choles-
terol. Individual peaks produced by methylene groups in the lower
portion of the perdeuterated palmitic chain are smeared out, unlike in
the spectrum for POPC-d31/SM/cholesterol where the equivalent peaks
remain relatively well resolved. The distinction was attributed to ex-
change of PDPC-d31 between PC-rich/cholesterol-poor and SM-rich/
cholesterol-rich domains on a timescale that is comparable to, as op-
posed to faster than in the case of POPC-d31, the difference in quadrupo-
lar splitting for the domains [63]. A larger domain size in the DHA-
containing system, on the order of the upper limit (b45 nm) estimated
in the OA-containing system, was then deduced on the basis of this as-
sessment. The transition to a spectrum at slightly lower temperature
(30 °C) reﬂecting a slower rate exchange of exchange between domains
was indicated by the splitting into two pairs of peaks (indicated by ar-
rows in the expanded region of the spectrum) of the central signal
from the terminal methyl groups in PDPC-d31 (Fig. 8, bottom left) [63].
With the enhanced resolution achieved by depaking, that there is
much greater intensity in the outer doublet assigned to the more or-
dered SM-rich/cholesterol-rich domain than in inner doublet assigned
to themore-disordered PC-rich/cholesterol-poor (non-raft) domain be-
comes clear (Fig. 8, top left). The majority of the DHA-containing PC
(~70%) was found in the raft-like domain. Because PC is less averse to
cholesterol than PE, we proposed PDPC is more able than PDPE to inﬁl-
trate a sterol-rich environment.
2H NMR spectra collected in parallel for PEPC-d31/SM/cholesterol
(1:1:1 mol), on the contrary, established that the EPA-containing PC is
largely conﬁned to non-raft regions [63]. The powder pattern spectrum
at 30 °C included in Fig. 8 (bottom right) is comprised of a narrow com-
ponent with edges at ±12 kHz that resembles the spectrum in the ab-
sence of cholesterol superposed upon a broad component with edges
at ±23 kHz. Slow exchange of PEPC-d31 between PC-rich/cholesterol-
poor and SM-rich/cholesterol-rich domains to which, respectively,these two spectral components were ascribed that must be N35 nm in
size to result in their individual observation was our interpretation
[64]. From the relative intensity of the pair doublets due to the terminal
methyl groups (identiﬁed by arrows) resolved in the depaked spectrum
(Fig. 8, upper right), most of the PEPC-d31 (~60%) was identiﬁed as
being in the non-raft domain. Slightly higher disorder for PEPC-d31
than PDPC-d31, as was observedwhen comparing order parameter pro-
ﬁles for SEPC-d35 vs. SDPC-d35 (Fig. 4), may render the EPA-containing
PC less compatible with insertion into an ordered domain.
6. Summary
In conclusion, a window into the complexity bywhich n-3 PUFA can
reorganize lipid microdomains emerges from studies on lipid bilayers
by solid state 2H NMR spectroscopy supplemented by complementary
biophysical techniques. Solid state 2H NMR experiments on PDPE-d31/
SM/cholesterol (1:1:1 mol) showed that when DHA is esteriﬁed to PE,
it segregates away from raft-like regions enriched in SM and cholesterol
that are nano-scale in size. This segregation is drivenby steric incompat-
ibility between highly disordered DHA chains and the rigid steroid
moiety of the sterol that is accentuated with the small head group of
PE. 2H NMR spectra for PDPC-d31/SM/cholesterol (1:1:1 mol) indicated,
contrastingly, that DHA esteriﬁed to PC inﬁltrates SM-rich/sterol-rich
nano-sized domains. These ﬁndings provide unprecedented mechanis-
tic insight into results from in vivo experiments on how n-3 PUFA dis-
rupt lipid microdomains.
218 S.R. Shaikh et al. / Biochimica et Biophysica Acta 1848 (2015) 211–219How the introduction of DHA-containing PE into a region of bulk
lipid surrounding a raft-like domain has the potential to push cholester-
ol into the raft and so increase molecular order within the domain is il-
lustrated in a cartoon presented in Fig. 9 (upper panel). This scenario,
although agreeing with the increased order observed in cells treated
with n-3 PUFA, does not reconcile with the redistribution of cholesterol
from DRM to DSM seen in cells by detergent extraction. One intriguing
possibility is to speculate that n-3 PUFA-containing PE molecules form
nanodomains, which is compatible with the size indicated by NMR in
model membranes, within a host microdomain that becomes more or-
dered because sphingolipid as well as cholesterol molecules are ex-
pelled. The NMR data establish that n-3 PUFA-containing PC can
incorporate into raft-like domains in lipid bilayers, consistent with de-
tergent extraction studies on cells that detected the uptake of EPA and
DHA into DRM. What the presence of PDPC or PEPC does to molecular
organization within the SM-rich/cholesterol-rich domain formed in
the model membrane is yet to be studied and experiments with PSM-
d31 are planned to directly probe order therein. It is an issue that has
to be addressed since the introduction of n-3 PUFA-containing PC into
an ordered raft-like domain, as depicted in a cartoon in Fig. 9 (lowerFig. 9. Schematic representation of the incorporation of n-3 PUFA-containing phospho-
lipids into a lipid monolayer. Themonolayer is comprised of a (raft-like) domain enriched
in sphingolipid and cholesterol that is ﬂanked on each side by a (non-raft) region contain-
ing monounsaturated phospholipid (bulk lipid) and depleted in cholesterol. In the upper
panel n-3 PUFA-containing PE prefers the non-raft region, redistributing cholesterol into
the raft-like domain that becomes more ordered. In the lower panel n-3 PUFA-
containing PC inﬁltrates the raft-like region, from which cholesterol is displaced into the
non-raft region and which becomes more disordered.panel), would be expected to displace sterol and disorder the domain.
The reverse, an increase in order, is typically reported in cells. A possible
explanation, interestingly, may lie in the reduction in the concentration
of AA in DRM that usually follows elevation in the amount of n-3 PUFA.
Order parametersmeasured for PDPC-d31 are higher (~6% in the plateau
region) than 1-[2H31]palmitoyl-2-arachidonylphosphatidylcholine
([2H31]16:0–20:4PC, PAPC-d31) [14], so that substituting DHA for AA
could be responsible for a rise in order.
In order to develop a complete mechanism by which n-3 PUFA re-
model lipid-protein signaling microdomains, extensive new studies
are still needed in several areas. One, it will be necessary to develop a
better understanding of how n-3 PUFA, upon uptake into other lipid
species (e.g. PS), impact the molecular organization of lipid microdo-
mains at the molecular and cellular levels. Second, the importance of
structural differences betweenn-3 PUFA is unknown. Elucidating the ef-
fects of shorter chain n-3 PUFA such as α-linolenic acid (18:3) and
stearidonic acid (18:4) is an entirely new area of investigation. In addi-
tion, it is not clear how EPA, its elongation production, DPA (22:5), and
DHA differ in their ability to target lipid microdomains. Recent studies
on lipid bilayers and cellular systems have shown that EPA and DHA
exert different effects on lipid microdomain size and order. To develop
methods that further bridge the gap between model membranes and
in vivo experiments will ultimately aid our understanding of the under-
lyingmechanisms bywhich n-3 PUFA remodel the architecture of cellu-
lar membranes.
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